CELLSCRIPT™ provides products and technologies for making and using RNA for translation in cells for clinical research and therapeutics, including RNA comprising pseudouridine (Ψ) and other modified nucleosides covered by patents licensed from the University of Pennsylvania. Products include enzymes and kits for in vitro transcription, co-transcriptional or post-transcriptional 5’ RNA capping, and 3’ RNA polyadenylation.
Looking for a particular CELLSCRIPT employee's phone or email?
The CELLSCRIPT annual revenue was $49.9 million in 2026.
Gary Dahl is the CEO of CELLSCRIPT.
36 people are employed at CELLSCRIPT.
CELLSCRIPT is based in Madison, Wisconsin.
The NAICS codes for CELLSCRIPT are [5417, 54, 541714, 54171, 541].
The SIC codes for CELLSCRIPT are [873, 87].